Fluoroquinolone antimicrobial drugs.
作者信息
Chan Tiffany, Bunce Paul E
机构信息
Department of Medicine (Chan, Bunce), University of Toronto; Division of Infectious Diseases (Bunce), University Health Network, Toronto, Ont.
出版信息
CMAJ. 2017 May 1;189(17):E638. doi: 10.1503/cmaj.160938.
Abstract
摘要
相似文献
1
Fluoroquinolone antimicrobial drugs.氟喹诺酮类抗菌药物。
CMAJ. 2017 May 1;189(17):E638. doi: 10.1503/cmaj.160938.
2
The newer fluoroquinolones.新型氟喹诺酮类药物。
Infect Dis Clin North Am. 2009 Dec;23(4):1027-51, x. doi: 10.1016/j.idc.2009.06.003.
3
Antimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniae.
J Antimicrob Chemother. 2006 Jun;57(6):1256-8. doi: 10.1093/jac/dkl144. Epub 2006 Apr 7.
4
Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France.法国西南部耐氟喹诺酮类生殖支原体
Emerg Infect Dis. 2016 Sep;22(9):1677-9. doi: 10.3201/eid2209.160446.
5
Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp.弯曲杆菌属中氟喹诺酮和大环内酯类抗生素耐药机制
Microbes Infect. 2006 Jun;8(7):1967-71. doi: 10.1016/j.micinf.2005.12.032. Epub 2006 Mar 29.
6
Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics.引起菌血症性肺炎球菌肺炎的肺炎球菌分离株的抗菌药物敏感性：使用当前断点和氟喹诺酮类药物动力学进行分析
Int J Antimicrob Agents. 2010 Jul;36(1):95-7. doi: 10.1016/j.ijantimicag.2010.02.021. Epub 2010 Apr 7.
7
Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).北美和欧洲分离出的耐氟喹诺酮β溶血性链球菌属的特征，包括耐氟喹诺酮解没食子酸链球菌亚种似马链球菌的首次报告：哨兵抗菌监测计划（1997 - 2004年）报告
Diagn Microbiol Infect Dis. 2006 Jun;55(2):119-27. doi: 10.1016/j.diagmicrobio.2005.12.006. Epub 2006 Mar 10.
8
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.生殖支原体对大环内酯类和氟喹诺酮类药物的耐药性不断增加。
Emerg Infect Dis. 2017 May;23(5):809-812. doi: 10.3201/eid2305.161745.
9
In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance.沙雷氏 Actinobaculum 体外药敏试验对 12 种抗菌药物的敏感性及氟喹诺酮类耐药的分子分析。
J Antimicrob Chemother. 2010 Dec;65(12):2514-7. doi: 10.1093/jac/dkq383. Epub 2010 Oct 14.
10
Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.转录激活因子RamA和SoxS对耐氟喹诺酮鼠伤寒沙门氏菌中多药外排泵AcrAB和AcrEF表达的影响。
J Antimicrob Chemother. 2009 Jan;63(1):95-102. doi: 10.1093/jac/dkn448. Epub 2008 Nov 4.
引用本文的文献
1
Pharmacokinetics of Antibiotics in Crocodiles: A Review.鳄鱼体内抗生素的药代动力学：综述
Animals (Basel). 2025 May 8;15(10):1363. doi: 10.3390/ani15101363.
2
Pharmacokinetics, Withdrawal Time, and Physiological Effects of Single Oral Administration of Enrofloxacin in Dybowski's Frog ().恩诺沙星单次口服给药在戴氏姬蛙体内的药代动力学、休药期及生理效应
Antibiotics (Basel). 2025 Apr 19;14(4):417. doi: 10.3390/antibiotics14040417.
3
Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A Retrospective Pharmacovigilance Study.氟喹诺酮类药物与其他抗生素相关不良反应的比较分析：一项回顾性药物警戒研究
Drug Healthc Patient Saf. 2025 Feb 5;17:51-62. doi: 10.2147/DHPS.S497112. eCollection 2025.
4
Recent Applications of Artificial Intelligence in Discovery of New Antibacterial Agents.人工智能在新型抗菌药物发现中的最新应用
Adv Appl Bioinform Chem. 2024 Dec 3;17:139-157. doi: 10.2147/AABC.S484321. eCollection 2024.
5
Risk of collagen-related disorders and neurological events among patients with uncomplicated urinary tract infection following short treatment with fluoroquinolones: a cohort study.氟喹诺酮类药物短期治疗单纯性尿路感染患者发生胶原相关疾病和神经事件的风险：一项队列研究
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0069024. doi: 10.1128/aac.00690-24. Epub 2024 Oct 29.
6
Pregnancy related adverse events and congenital disorders associated with fluoroquinolones: A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).与氟喹诺酮类药物相关的妊娠不良事件和先天性疾病：对美国食品药品监督管理局不良事件报告系统（FAERS）的一项真实世界药物警戒研究。
Heliyon. 2024 Sep 7;10(18):e37547. doi: 10.1016/j.heliyon.2024.e37547. eCollection 2024 Sep 30.
7
Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics.同时使用直接口服抗凝药物和大环内酯类或氟喹诺酮类抗生素治疗的患者中的出血事件。
Br J Clin Pharmacol. 2023 Feb;89(2):887-897. doi: 10.1111/bcp.15531. Epub 2022 Oct 9.
8
Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis.氟喹诺酮类药物会增加主动脉瘤或主动脉夹层的发生率及死亡率吗？一项系统评价与荟萃分析。
Front Cardiovasc Med. 2022 Aug 9;9:949538. doi: 10.3389/fcvm.2022.949538. eCollection 2022.
9
The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis.强化氨基糖苷类/头孢菌素治疗在氟喹诺酮类耐药细菌性角膜炎中的一线治疗价值。
Turk J Ophthalmol. 2020 Oct 30;50(5):258-263. doi: 10.4274/tjo.galenos.2020.37346.
10
N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria.氟喹诺酮类的N1-苯并稠合修饰降低了对革兰氏阴性菌的活性。
ACS Omega. 2020 May 18;5(21):11923-11934. doi: 10.1021/acsomega.9b03910. eCollection 2020 Jun 2.
本文引用的文献
1
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.门诊患者中分离出的耐氟喹诺酮大肠杆菌尿菌株常对多种药物耐药：北美尿路感染协作联盟-喹诺酮耐药性研究结果
Antimicrob Agents Chemother. 2006 Jun;50(6):2251-4. doi: 10.1128/AAC.00123-06.
2
New uses for new and old quinolones and the challenge of resistance.新旧喹诺酮类药物的新用途及耐药性挑战
Clin Infect Dis. 2000 Feb;30(2):243-54. doi: 10.1086/313677.
3
Fluoroquinolone toxicity profiles: a review focusing on newer agents.氟喹诺酮类药物的毒性概况：聚焦新型药物的综述
Clin Infect Dis. 1999 Feb;28(2):352-64. doi: 10.1086/515104.
Zotero 插件